Li Ma 编辑 at IgMin Research
Our vision is to connect scientists across various fields to enhance shared knowledge growth.
简历
Li Ma holds a Ph.D. in Radiochemistry from the University of Missouri and a Master's in Organic Chemistry from Southern Illinois University Edwardsville. She is currently a Scientist I at Invicro LLC (Perceptive) in Boston, MA, specializing in drug discovery for cancer oncology and inflammation diseases. Her research spans radiopharmaceutical development, pre-clinical and clinical evaluations, nuclear medicine imaging, and therapy. She has experience in PET/MRI imaging, radiotherapy, tissue handling, cell culture, in vivo animal models, and in vitro bioassays.
Li Ma has 11 peer-reviewed publications in high-impact journals, including Science Translational Medicine, Biochemistry, Bioconjugation Chemistry, Inorganic Chemistry, and Nuclear Medicine Biology. She has received multiple awards and fellowships, including the Troutner Fellowship in Radiochemistry, Pacifichem Student Travel Bursary, and David Troutner Fellowship.
She is an active reviewer for two scientific journals and has served in professional memberships such as SNMMI (Society of Nuclear Medicine and Molecular Imaging) and ACS (American Chemical Society).
Her research contributions focus on novel radiopharmaceutical agents, biomarker imaging, and targeted therapies for oncology.
研究兴趣
Radiochemistry & Radiopharmaceutical Development, Drug Discovery & Targeted Therapy, Molecular Imaging & Nuclear Medicine
Editor
工作详情
Scientist I, Discovery and Research
University of Missouri
Radiochemistry, Drug Discovery & Development
USA
贡献按题领域
探索 IgMin 科目
现在哪些文章在热门？
研究文章
- Efficient Room Temperature Ethanol Vapor Sensing by Unique Fractal Features of Tin Oxide
- EB Naevi-like Lesion in Infant Bullous Pemphigoid
- Development of a Mechanical Seal Closed Design Model
- Correlation between Different Factors of Non-point Source Pollution in Yangtze River Basin
- Application of Virtual Reality (VR) in Facility Management Competency-based Training (CBT) in the Era of Industrie 5.0
- LC-MS and HPLC-UV for Detecting Uremic Toxins: Two Validated Methods with Simultaneous Sensitivity and Specificity Evaluation
